FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for XTAMPZA ER (oxycodone) from Collegium Pharmaceutical, Inc. The approval authorizes changes under a supplemental NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• XTAMPZA ER (Oxycodone)

Snippet

SUPPL AP for XTAMPZA ER (OXYCODONE)